Security record · archived quarter
RXST
RxSight, Inc. · Healthcare · Medical - Devices
12Tracked holders
0Δ holders
5.10MShares held
$175.38MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +26.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | — | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | — | — |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | — | −1 |
| Q2 2024 | 12 | — | 2.73M | $164.29M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 1.01M | +77.5% | $34.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 994.17K | +369.5% | $34.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 994.17K | +369.5% | $34.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 890.80K | — | $30.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 830.76K | +1.7% | $28.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 830.76K | +1.7% | $28.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 398.91K | -4.8% | $13.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 398.91K | -4.8% | $13.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 398.91K | -4.8% | $13.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 398.91K | -4.8% | $13.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 391.73K | -12.4% | $13.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 361.50K | +102.9% | $12.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 127.35K | -54.9% | $4.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 50.15K | -18.1% | $1.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 50.15K | -18.1% | $1.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 22.37K | +0.5% | $769,012 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 16.18K | -59.6% | $557,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 9.57K | -90.7% | $329,017 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 162 holders, 37.72M shares, $223.80M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API